DE602004019541D1 - Cycloalkyläbü kondensierte indole - Google Patents
Cycloalkyläbü kondensierte indoleInfo
- Publication number
- DE602004019541D1 DE602004019541D1 DE602004019541T DE602004019541T DE602004019541D1 DE 602004019541 D1 DE602004019541 D1 DE 602004019541D1 DE 602004019541 T DE602004019541 T DE 602004019541T DE 602004019541 T DE602004019541 T DE 602004019541T DE 602004019541 D1 DE602004019541 D1 DE 602004019541D1
- Authority
- DE
- Germany
- Prior art keywords
- cycloalkyläbü
- condensed indole
- indole
- condensed
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US49784503P | 2003-08-26 | 2003-08-26 | |
PCT/US2004/017982 WO2005023245A1 (en) | 2003-08-26 | 2004-06-07 | Novel cycloalkyl’b! condensed indoles |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602004019541D1 true DE602004019541D1 (de) | 2009-04-02 |
Family
ID=34272613
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602004019541T Active DE602004019541D1 (de) | 2003-08-26 | 2004-06-07 | Cycloalkyläbü kondensierte indole |
Country Status (7)
Country | Link |
---|---|
US (1) | US7622494B2 (de) |
EP (1) | EP1658068B1 (de) |
JP (1) | JP2007503434A (de) |
AT (1) | ATE422885T1 (de) |
DE (1) | DE602004019541D1 (de) |
ES (1) | ES2320663T3 (de) |
WO (1) | WO2005023245A1 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007509057A (ja) * | 2003-10-15 | 2007-04-12 | カイロン コーポレイション | ウイルス阻害のための組成物および方法 |
WO2006012310A2 (en) * | 2004-06-25 | 2006-02-02 | Genzyme Corporation | Carbazole derivatives for treating polycystic kidney disease |
WO2006121466A2 (en) * | 2004-11-22 | 2006-11-16 | Smithkline Beecham Corporation | Hcv inhibitors |
WO2013139929A1 (en) * | 2012-03-22 | 2013-09-26 | Ludwig-Maximilians-Universität München | Novel means and methods for treating diseases of the central nervous system, metabolic and cardiac diseases and aging |
JP6653573B2 (ja) | 2012-05-22 | 2020-02-26 | トラスティーズ・オブ・ダートマウス・カレッジ | シクロアルカニル[b]インドール、シクロアルカニル[b]ベンゾフラン、シクロアルカニル[b]ベンゾチオフェンを合成するための方法、化合物および使用の方法 |
EP2895462A1 (de) * | 2012-09-13 | 2015-07-22 | Baden-Württemberg Stiftung gGmbH | Spezifische inhibitoren von protein p21 als therapeutika |
WO2016196664A1 (en) * | 2015-06-01 | 2016-12-08 | Cedars-Sinai Medical Center | Methods and use of compounds that bind to rela of nf-kb |
US10882821B1 (en) | 2017-09-26 | 2021-01-05 | The Board Of Trustees Of The Leland Stanford Junior University | Enantiomeric compound for the reduction of the deleterious activity of extended nucleotide repeat containing genes |
US20220062233A1 (en) * | 2018-12-18 | 2022-03-03 | The Board Of Trustees Of The Leland Stanford Junior University | Compounds for the Reduction of the Deleterious Activity of Extended Nucleotide Repeat Containing Genes |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001043741A1 (en) | 1999-12-16 | 2001-06-21 | Arizona Board Of Regents Acting For And On Behalf Of Arizona State University | Cytotoxic n-unsubstituted indoles and cyclopent(b)indoles and method of making and using same |
US20040009613A1 (en) | 2001-02-16 | 2004-01-15 | Ming-Ming Zhou | Methods of identifying modulators of bromodomains |
US20030139609A1 (en) | 2001-09-10 | 2003-07-24 | Skibo Edward B. | Aziridinyl quinone antitumor agents based on indoles and cyclopent[b]indoles |
JP2006508134A (ja) | 2002-11-08 | 2006-03-09 | グラクソ グループ リミテッド | 医薬組成物 |
KR20060017545A (ko) | 2003-06-10 | 2006-02-23 | 스미스클라인 비참 코포레이션 | 테트라하이드로카르바졸 유도체 및 이들의 약제학적 용도 |
-
2004
- 2004-06-07 WO PCT/US2004/017982 patent/WO2005023245A1/en active Application Filing
- 2004-06-07 EP EP04754553A patent/EP1658068B1/de active Active
- 2004-06-07 JP JP2006524621A patent/JP2007503434A/ja active Pending
- 2004-06-07 ES ES04754553T patent/ES2320663T3/es active Active
- 2004-06-07 AT AT04754553T patent/ATE422885T1/de not_active IP Right Cessation
- 2004-06-07 US US10/569,524 patent/US7622494B2/en not_active Expired - Fee Related
- 2004-06-07 DE DE602004019541T patent/DE602004019541D1/de active Active
Also Published As
Publication number | Publication date |
---|---|
EP1658068A1 (de) | 2006-05-24 |
ES2320663T3 (es) | 2009-05-27 |
US20060281804A1 (en) | 2006-12-14 |
US7622494B2 (en) | 2009-11-24 |
WO2005023245A1 (en) | 2005-03-17 |
ATE422885T1 (de) | 2009-03-15 |
EP1658068B1 (de) | 2009-02-18 |
JP2007503434A (ja) | 2007-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20055741D0 (no) | Nye kjemiske forbindelser | |
DE602004024572D1 (de) | Zusammensetzungen, die sich als inhibitoren von proteinkinasen eignen | |
WO2006015035A8 (en) | Useful compounds for hpv infection | |
ATE433973T1 (de) | Azolylaminoazine als inhibitoren von proteinkinasen | |
DE602004014117D1 (de) | Thiazole zur verwendung als inhibitoren von protein-kinasen | |
EA200700175A1 (ru) | Композиции и способы лечения воспалительных заболеваний | |
ATE482213T1 (de) | Als inhibitoren von proteinkinasen geeignete pyrazoloä1,5-aüpyrimidine | |
ATE466580T1 (de) | Azolylaminoazine als proteinkinasehemmer | |
ATE468336T1 (de) | Azolylaminoazine als proteinkinasehemmer | |
ATE365733T1 (de) | Zusammensetzungen brauchbar als protein-kinase- inhibitoren | |
ATE425965T1 (de) | 1,2,3,4-tetrasubstituiertes indol zur behandlung von atemwegserkrankungen | |
ATE464303T1 (de) | Als inhibitoren von rock und anderen proteinkinasen geeignete zusammensetzungen | |
BRPI0414599A (pt) | pirrol-indóis substituìdos | |
NO20064325L (no) | Heteroarylaminopyrazolderivativer nyttige for behandling av diabetes | |
ATE450530T1 (de) | Zusammensetzungen zur verwendung als protein- kinase-inhibitoren | |
DK1654253T3 (da) | Substituerede 3-pyrrolidinindolderivater | |
EA200601288A1 (ru) | Производные 1,3-дифенилпроп-2-ен-1-она, способ их получения и применение | |
NO20055563L (no) | Midler for behandlingen av lavere abdominale lidelser | |
DE602006017574D1 (de) | Als protein-kinase-inhibitoren nutzbare benzimidazole | |
ATE389651T1 (de) | Als inhibitoren von c-met geeignete pyrrolzusammensetzungen | |
SE0302304D0 (sv) | Novel compounds | |
DE602004019541D1 (de) | Cycloalkyläbü kondensierte indole | |
ATE410235T1 (de) | Behandlung von ballastwasser | |
ATE432275T1 (de) | Pyrrol- bzw. imidazolamide zur behandlung von obesitas | |
DE60142786D1 (de) | Zusammensetzungen und methoden zur behandlung von candidosen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |